Catheter ablation of atrial fibrillation in patients with diabetes mellitus

著者: Allen Wang, Tracy Truong, Eric Black‐Maier, Cynthia L. Green, Kristen Bova Campbell, Adam S. Barnett, Janice Febre, Zak Loring, Sana M. Al‐Khatib, Brett D. Atwater, James P. Daubert, Camille Frazier‐Mills, Donald D. Hegland, Kevin Jackson, Larry R. Jackson, Jason I. Koontz, Robert K. Lewis, Sean D. Pokorney, Albert Y. Sun, Kevin L. Thomas, Tristam D. Bahnson, Jonathan P. Piccini - Heart Rhythm O2 2020 被引用: 41

BACKGROUND: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM. OBJECTIVE: The purpose of this study was to compare AF ablation outcomes in patients with and those without DM. METHODS: We performed a retrospective analysis of 351 consecutive patients who underwent first-time AF ablation. Clinical outcomes included freedom from recurrent atrial arrhythmia, symptom burden (Mayo AF Symptom Inventory score), cardiovascular and all-cause hospitalizations, and periprocedural complications. RESULTS: = .064). CONCLUSION: Although safety outcomes associated with AF ablation were similar between patients with and those without DM, arrhythmia-free survival was significantly lower among patients with DM. Poor glycemic control seems to an important risk factor for AF recurrence.